Medtronic plc (MDT) EV/EBITDA Ratio: 13.03x
Is Medtronic plc’s EV/EBITDA ratio high or low?
Medtronic plc's EV/EBITDA ratio of 13.03x is 23% below its 5-year average of 17.02x, near the low end of its 5-year range (13.03x–31.94x).
The EV/EBITDA ratio for Medtronic plc (MDT) is 13.03x as of Wednesday, June 10, 2026. It is below its 12-month average by 16.89% (15.68x).
MDT EV/EBITDA Ratio Chart
MDT Average EV/EBITDA Ratio Chart
MDT Current vs Average EV/EBITDA Ratio Chart
MDT EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
13.03x
EV/EBITDA RATIO AVG TTM
15.68x
EV/EBITDA RATIO AVG 3Y
15.65x
EV/EBITDA RATIO AVG 5Y
17.02x
EV/EBITDA RATIO AVG 10Y
17.74x
EV/EBITDA RATIO AVG 15Y
16.52x
EV/EBITDA RATIO AVG 20Y
15.70x
CURRENT VS TTM AVG
-16.89%
CURRENT VS 3Y AVG
-16.76%
CURRENT VS 5Y AVG
-23.46%
CURRENT VS 10Y AVG
-26.57%
CURRENT VS 15Y AVG
-21.14%
CURRENT VS 20Y AVG
-17.01%
MDT Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | — | 13.03x | 15.68x | 15.65x | 17.02x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 20.92x | 22.99x | 82.30x | 54.94x |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 10.82x | 9.64x | 16.60x | 15.48x |
| Elevance Health Inc. (ELV) | $87.43B | 12.44x | 10.05x | 11.31x | 12.23x |
| CVS Health Corporation (CVS) | $125.16B | 17.45x | 14.88x | 11.86x | 12.00x |
| Cigna Corporation (CI) | $78.25B | 8.55x | 8.37x | 9.19x | 9.50x |
| Danaher Corporation (DHR) | $130.25B | 21.52x | 23.46x | 23.88x | 22.36x |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 11.35x | 12.73x | 17.20x | 14.74x |
| Pfizer Inc. (PFE) | $146.36B | 12.38x | 10.50x | 15.94x | 13.74x |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 39.06x | 52.49x | 59.81x | 55.90x |
EV/EBITDA vs. its own history
At 13.0, EV/EBITDA is cheaper than usual — richer than 24% of its 20-year range.
20-year low
7.0
median
15.6
20-year high
33.0
Understanding EV/EBITDA
Enterprise Value (EV) = Market Cap + Total Debt - Cash
EBITDA = Earnings Before Interest, Taxes, Depreciation & Amortization
EV/EBITDA is commonly used for comparing companies because:
- It accounts for debt levels (capital structure neutral)
- It removes effects of different depreciation policies
- It can be compared across countries with different tax rates
- It can remain available when net income is negative, if EBITDA is positive
Medtronic plc EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Medtronic plc (MDT)?
- The EV/EBITDA ratio for MDT stock is 13.03x.
- Is Medtronic plc's EV/EBITDA ratio high or low?
- Medtronic plc's EV/EBITDA ratio of 13.03x is 23% below its 5-year average of 17.02x, near the low end of its 5-year range (13.03x–31.94x).
- What is the TTM average EV/EBITDA ratio for Medtronic plc (MDT)?
- The TTM average EV/EBITDA ratio for MDT stock is 15.68x.
- What is the 3Y average EV/EBITDA ratio for Medtronic plc (MDT)?
- The 3Y average EV/EBITDA ratio for MDT stock is 15.65x.
- What is the 5Y average EV/EBITDA ratio for Medtronic plc (MDT)?
- The 5Y average EV/EBITDA ratio for MDT stock is 17.02x.
- What is the 10Y average EV/EBITDA ratio for Medtronic plc (MDT)?
- The 10Y average EV/EBITDA ratio for MDT stock is 17.74x.
- What is the 15Y average EV/EBITDA ratio for Medtronic plc (MDT)?
- The 15Y average EV/EBITDA ratio for MDT stock is 16.52x.
- What is the 20Y average EV/EBITDA ratio for Medtronic plc (MDT)?
- The 20Y average EV/EBITDA ratio for MDT stock is 15.70x.
Medtronic plc EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-02 | 13.03x |
| 2026-06-01 | 13.06x |
| 2026-05-29 | 13.04x |
| 2026-05-28 | 13.28x |
| 2026-05-27 | 13.34x |
| 2026-05-26 | 13.56x |
| 2026-05-22 | 13.70x |
| 2026-05-21 | 13.64x |
| 2026-05-20 | 13.64x |
| 2026-05-19 | 13.70x |
| 2026-05-18 | 13.52x |
| 2026-05-15 | 13.36x |
| 2026-05-14 | 13.48x |
| 2026-05-13 | 13.37x |
| 2026-05-12 | 13.45x |
| 2026-05-11 | 13.14x |
| 2026-05-08 | 13.36x |
| 2026-05-07 | 13.61x |
| 2026-05-06 | 13.56x |
| 2026-05-05 | 13.59x |
| 2026-05-04 | 13.66x |
| 2026-05-01 | 13.89x |
| 2026-04-30 | 14.03x |
| 2026-04-29 | 13.81x |
| 2026-04-28 | 14.15x |
| 2026-04-27 | 14.29x |
| 2026-04-24 | 14.35x |
| 2026-04-23 | 14.41x |
| 2026-04-22 | 14.34x |
| 2026-04-21 | 14.17x |
| 2026-04-20 | 14.58x |
| 2026-04-17 | 14.74x |
| 2026-04-16 | 14.67x |
| 2026-04-15 | 14.87x |
| 2026-04-14 | 15.01x |
| 2026-04-13 | 14.99x |
| 2026-04-10 | 14.89x |
| 2026-04-09 | 14.98x |
| 2026-04-08 | 15.08x |
| 2026-04-07 | 14.78x |
| 2026-04-06 | 14.76x |
| 2026-04-02 | 14.81x |
| 2026-04-01 | 14.73x |
| 2026-03-31 | 14.81x |
| 2026-03-30 | 14.68x |
| 2026-03-27 | 14.88x |
| 2026-03-26 | 14.95x |
| 2026-03-25 | 14.98x |
| 2026-03-24 | 14.80x |
| 2026-03-23 | 14.88x |
| 2026-03-20 | 14.74x |
| 2026-03-19 | 14.84x |
| 2026-03-18 | 14.89x |
| 2026-03-17 | 15.05x |
| 2026-03-16 | 15.03x |
| 2026-03-13 | 14.88x |
| 2026-03-12 | 14.91x |
| 2026-03-11 | 15.13x |
| 2026-03-10 | 15.25x |
| 2026-03-09 | 15.45x |
| 2026-03-06 | 15.39x |
| 2026-03-05 | 15.68x |
| 2026-03-04 | 16.04x |
| 2026-03-03 | 16.19x |
| 2026-03-02 | 16.38x |
| 2026-02-27 | 16.32x |
| 2026-02-26 | 16.24x |
| 2026-02-25 | 16.19x |
| 2026-02-24 | 16.20x |
| 2026-02-23 | 16.70x |
| 2026-02-20 | 16.46x |
| 2026-02-19 | 16.56x |
| 2026-02-18 | 16.68x |
| 2026-02-17 | 16.39x |
| 2026-02-13 | 16.82x |
| 2026-02-12 | 17.01x |
| 2026-02-11 | 17.04x |
| 2026-02-10 | 17.09x |
| 2026-02-09 | 17.12x |
| 2026-02-06 | 17.29x |
| 2026-02-05 | 17.30x |
| 2026-02-04 | 17.15x |
| 2026-02-03 | 17.33x |
| 2026-02-02 | 17.27x |
| 2026-01-30 | 17.30x |
| 2026-01-29 | 17.03x |
| 2026-01-28 | 17.00x |
| 2026-01-27 | 16.99x |
| 2026-01-26 | 16.98x |
| 2026-01-23 | 17.01x |
| 2026-01-22 | 17.08x |
| 2026-01-21 | 16.93x |
| 2026-01-20 | 16.70x |
| 2026-01-16 | 16.44x |
| 2026-01-15 | 16.75x |
| 2026-01-14 | 16.72x |
| 2026-01-13 | 16.39x |
| 2026-01-12 | 16.47x |
| 2026-01-09 | 16.55x |
| 2026-01-08 | 16.71x |
| 2026-01-07 | 16.86x |
| 2026-01-06 | 16.93x |
| 2026-01-05 | 16.52x |
| 2026-01-02 | 16.34x |
| 2025-12-31 | 16.34x |
| 2025-12-30 | 16.43x |
| 2025-12-29 | 16.36x |
| 2025-12-26 | 16.41x |
| 2025-12-24 | 16.51x |
| 2025-12-23 | 16.54x |
| 2025-12-22 | 16.57x |
| 2025-12-19 | 16.70x |
| 2025-12-18 | 16.68x |
| 2025-12-17 | 16.66x |
| 2025-12-16 | 16.57x |
| 2025-12-15 | 16.69x |
| 2025-12-12 | 16.87x |
| 2025-12-11 | 16.86x |
| 2025-12-10 | 17.00x |
| 2025-12-09 | 16.84x |
| 2025-12-08 | 17.07x |
| 2025-12-05 | 17.08x |
| 2025-12-04 | 17.17x |
| 2025-12-03 | 17.17x |
| 2025-12-02 | 17.17x |
| 2025-12-01 | 17.36x |
| 2025-11-28 | 17.63x |
| 2025-11-26 | 17.59x |
| 2025-11-25 | 17.63x |
| 2025-11-24 | 17.14x |
| 2025-11-21 | 16.86x |
| 2025-11-20 | 16.61x |
| 2025-11-19 | 16.74x |
| 2025-11-18 | 16.81x |
| 2025-11-17 | 16.18x |
| 2025-11-14 | 16.13x |
| 2025-11-13 | 16.16x |
| 2025-11-12 | 16.12x |
| 2025-11-11 | 16.06x |
| 2025-11-10 | 15.69x |
| 2025-11-07 | 15.62x |
| 2025-11-06 | 15.33x |
| 2025-11-05 | 15.37x |
| 2025-11-04 | 15.38x |
| 2025-11-03 | 15.35x |
| 2025-10-31 | 15.42x |
| 2025-10-30 | 15.45x |
| 2025-10-29 | 15.56x |
| 2025-10-28 | 15.76x |
| 2025-10-27 | 15.89x |
| 2025-10-24 | 15.82x |
| 2025-10-23 | 15.90x |
| 2025-10-22 | 16.13x |
| 2025-10-21 | 16.12x |
| 2025-10-20 | 16.13x |
| 2025-10-17 | 16.12x |
| 2025-10-16 | 16.01x |
| 2025-10-15 | 16.05x |
| 2025-10-14 | 16.22x |
| 2025-10-13 | 16.09x |
| 2025-10-10 | 16.07x |
| 2025-10-09 | 16.21x |
| 2025-10-08 | 16.40x |
| 2025-10-07 | 16.47x |
| 2025-10-06 | 16.48x |
| 2025-10-03 | 16.38x |
| 2025-10-02 | 16.07x |
| 2025-10-01 | 15.98x |
| 2025-09-30 | 16.04x |
| 2025-09-29 | 15.87x |
| 2025-09-26 | 15.90x |
| 2025-09-25 | 15.91x |
| 2025-09-24 | 16.11x |
| 2025-09-23 | 16.00x |
| 2025-09-22 | 15.96x |
| 2025-09-19 | 16.02x |
| 2025-09-18 | 16.09x |
| 2025-09-17 | 15.95x |
| 2025-09-16 | 15.90x |
| 2025-09-15 | 15.79x |
| 2025-09-12 | 15.87x |
| 2025-09-11 | 15.90x |
| 2025-09-10 | 15.64x |
| 2025-09-09 | 15.88x |
| 2025-09-08 | 15.73x |
| 2025-09-05 | 15.72x |
| 2025-09-04 | 15.71x |
| 2025-09-03 | 15.63x |
| 2025-09-02 | 15.78x |
| 2025-08-29 | 15.71x |
| 2025-08-28 | 15.59x |
| 2025-08-27 | 15.60x |
| 2025-08-26 | 15.62x |
| 2025-08-25 | 15.71x |
| 2025-08-22 | 15.80x |
| 2025-08-21 | 15.58x |
| 2025-08-20 | 15.88x |
| 2025-08-19 | 15.41x |
| 2025-08-18 | 15.82x |
| 2025-08-15 | 15.85x |
| 2025-08-14 | 15.70x |
| 2025-08-13 | 15.83x |
| 2025-08-12 | 15.72x |
| 2025-08-11 | 15.81x |
| 2025-08-08 | 15.83x |
| 2025-08-07 | 15.60x |
| 2025-08-06 | 15.34x |
| 2025-08-05 | 15.38x |
| 2025-08-04 | 15.38x |
| 2025-08-01 | 15.33x |
| 2025-07-31 | 15.46x |
| 2025-07-30 | 15.65x |
| 2025-07-29 | 15.77x |
| 2025-07-28 | 15.70x |
| 2025-07-25 | 15.84x |
| 2025-07-24 | 15.75x |
| 2025-07-23 | 15.71x |
| 2025-07-22 | 15.66x |
| 2025-07-21 | 15.38x |
| 2025-07-18 | 15.37x |
| 2025-07-17 | 15.36x |
| 2025-07-16 | 15.39x |
| 2025-07-15 | 15.32x |
| 2025-07-14 | 15.39x |
| 2025-07-11 | 15.41x |
| 2025-07-10 | 15.34x |
| 2025-07-09 | 15.29x |
| 2025-07-08 | 15.23x |
| 2025-07-07 | 15.10x |
| 2025-07-03 | 15.20x |
| 2025-07-02 | 15.19x |
| 2025-07-01 | 15.25x |
| 2025-06-30 | 15.03x |
| 2025-06-27 | 14.87x |
| 2025-06-26 | 14.89x |
| 2025-06-25 | 14.86x |
| 2025-06-24 | 14.88x |
| 2025-06-23 | 14.86x |
| 2025-06-20 | 14.91x |
| 2025-06-18 | 15.67x |
| 2025-06-17 | 15.74x |
| 2025-06-16 | 16.00x |
| 2025-06-13 | 15.90x |
| 2025-06-12 | 16.08x |
| 2025-06-11 | 16.02x |
| 2025-06-10 | 16.00x |
| 2025-06-09 | 15.93x |
| 2025-06-06 | 15.93x |
| 2025-06-05 | 15.86x |
| 2025-06-04 | 15.65x |
| 2025-06-03 | 15.64x |
| 2025-06-02 | 15.38x |
| 2025-05-30 | 15.26x |
| 2025-05-29 | 15.18x |
| 2025-05-28 | 15.01x |
| 2025-05-27 | 15.00x |
| 2025-05-23 | 14.92x |
| 2025-05-22 | 14.96x |
| 2025-05-21 | 15.48x |
| 2025-05-20 | 15.77x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha